600998 (Jointown Pharmaceutical Group Co Ltd) vs Shanghai Composite Comparison

600998

Shanghai Composite

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

600998

Shanghai Composite

Difference

1Y 3Y 5Y 10Y 15Y 20Y

600998

Shanghai Composite

Add Stock

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Shanghai Composite

600998

MCK

COR

0HF3

CAH

Add Stock

1Y 3Y 5Y 10Y 15Y 20Y

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Jointown Pharmaceutical Group Co Ltd
Glance View

Market Cap

24.3B CNY

Industry

Health Care

In the sprawling landscape of the Chinese pharmaceutical industry, Jointown Pharmaceutical Group Co. Ltd. has emerged as a significant player, knitting together a vast network that facilitates the distribution of pharmaceutical products across the nation. Founded in 1999 and headquartered in Wuhan, Jointown has adeptly navigated the complexities of China's healthcare demands, becoming the country's largest privately-owned pharmaceutical wholesaler. The company’s operations span the procurement, distribution, and sale of a myriad of pharmaceutical products, medical devices, and healthcare supplies, effectively serving hospitals, clinics, and pharmacies through its extensive logistics and distribution channels. By leveraging cutting-edge technology to enhance its supply chain efficiency, Jointown ensures timely delivery and accessibility of medicines across urban and rural areas, thereby playing a pivotal role in supporting China's healthcare system. Jointown’s business model capitalizes on its robust logistical capabilities and comprehensive distribution network, which underpin its revenue streams. Through strategic partnerships with numerous domestic and international manufacturers, the company offers an impressive portfolio of pharmaceutical and healthcare products, maintaining a careful balance between proprietary and third-party offerings. This diversity in product offerings not only stabilizes its revenue base but also positions Jointown favorably in a highly competitive market. By continually expanding its e-commerce platforms and digital interfaces, the company fosters direct interaction with consumers, enhancing customer engagement and opening new revenue avenues. In essence, Jointown's prowess lies in its ability to integrate traditional distribution methods with innovative digital solutions, ensuring the company’s sustained growth and relevance in the ever-evolving pharmaceutical industry.

View Jointown Pharmaceutical Group Co Ltd Analysis

Intrinsic Value

What is Intrinsic Value?

Economic Moat is a concept popularized by Warren Buffett to describe a company's durable competitive advantage. It represents the 'moat' that protects a company from competitors and helps it sustain profitability over the long term. Our analysis of the past 10 years showed that companies with a wide economic moat significantly outperformed the market, delivering +645% returns compared to +189% for the S&P 500.

Our research into Economic Moat performance spans the past 10 years and focuses on companies with a wide economic moat. For this analysis, we calculated the average stock price returns of these companies, comparing them to the performance of the S&P 500 index over the same period.

The results were compelling: wide moat stocks achieved a remarkable +645% average return, compared to +188% for the broader market. This difference highlights the long-term benefits of investing in businesses that can maintain their market position and pricing power over time.

Note: This research does not account for survivorship bias. Past performance is not indicative of future results.

Determining whether a company has an economic moat requires both a deep dive into financial metrics and a qualitative assessment of its competitive position. Our analysts conduct a rigorous evaluation that focuses on identifying structural advantages that enable a company to sustain profitability and defend its market share over the long term.

The process begins with an analysis of a company’s historical financial performance. We assess how consistently the company has generated returns above its cost of capital and whether those returns have been stable or improving. However, financial performance alone doesn’t reveal the full picture. To understand the sources of these advantages, we evaluate five key drivers of economic moats:

Network Effect: We analyze whether the value of a company’s product or service grows as its user base expands. Platforms like payment systems or marketplaces benefit from this self-reinforcing.

Switching Costs: We assess whether customers face significant costs or disruptions when switching to a competitor’s product or service. High switching costs create customer stickiness and provide pricing power.

Intangible Assets: Strong brands, patents, and regulatory licenses can protect a company’s market position by creating barriers for competitors or enabling premium pricing. For example, a well-recognized consumer brand may command higher customer loyalty and margins.

Efficient scale: Occurs when a market is optimally served by one or a few players, making it unprofitable for new entrants to compete. This typically happens in industries with high fixed costs or geographic constraints, such as utilities or pipelines.

Cost Advantage: Companies with structural cost advantages can produce goods or services at a lower cost than their competitors, enabling them to offer competitive pricing or maintain higher margins. These advantages often arise from economies of scale, superior supply chain management, or proprietary technology. Firms like Walmart leverage their massive scale to negotiate better terms with suppliers, allowing them to undercut competitors on price.

By examining these factors in combination with a company’s financial performance and market positioning, we classify each company into one of three categories:

This rigorous evaluation ensures that our moat ratings are both comprehensive and reliable, giving investors the tools they need to make well-informed, long-term decisions.

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US		Mckesson Corp NYSE:MCK	Select
US		Cencora Inc NYSE:COR	Select
US	A	Amerisourcebergen Corp LSE:0HF3	Select
US		Cardinal Health Inc NYSE:CAH	Select
US		Henry Schein Inc NASDAQ:HSIC	Select
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Select
CN		Sinopharm Group Co Ltd HKEX:1099	Select
CN		Huadong Medicine Co Ltd SZSE:000963	Select
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Select
IT		Amplifon SpA MIL:AMP	Select

US		Mckesson Corp NYSE:MCK	Add
US		Cencora Inc NYSE:COR	Add
US	A	Amerisourcebergen Corp LSE:0HF3	Add
US		Cardinal Health Inc NYSE:CAH	Add
US		Henry Schein Inc NASDAQ:HSIC	Add
KR		Celltrion Healthcare Co Ltd KOSDAQ:091990	Add
CN		Sinopharm Group Co Ltd HKEX:1099	Add
CN		Huadong Medicine Co Ltd SZSE:000963	Add
CN		Shanghai Pharmaceuticals Holding Co Ltd SSE:601607	Add
IT		Amplifon SpA MIL:AMP	Add

US	G	GE Vernova LLC NYSE:GEV	Add
NL	N	Nepi Rockcastle NV JSE:NRP	Add
US		Schlumberger NV NYSE:SLB	Add
US	B	Baker Hughes Co NASDAQ:BKR	Add
ID		Amman Mineral Internasional Tbk PT IDX:AMMN	Add
US	R	Reddit Inc NYSE:RDDT	Add
CH	G	Galderma Group AG SIX:GALD	Add
US		Halliburton Co NYSE:HAL	Add
LU		Tenaris SA MIL:TEN	Add
IN		Jio Financial Services Ltd NSE:JIOFIN	Add

	Franklin Covey Co NYSE:FC	30.78 USD -12.8%
	Mohawk Industries Inc NYSE:MHK	117.95 USD -0.28%
	Ardmore Shipping Corp NYSE:ASC	13.48 USD 7.32%
	ASGN Inc NYSE:ASGN	85.435 USD -1.71%
	Skyworks Solutions Inc NASDAQ:SWKS	90.93 USD -1.84%
	Weatherford International PLC NASDAQ:WFRD	71.32 USD -1.12%

600998

vs

Shanghai Composite

Stocks Performance
600998 vs Shanghai Composite

Performance Gap
600998 vs Shanghai Composite

Performance By Year
600998 vs Shanghai Composite

Competitors Performance
Jointown Pharmaceutical Group Co Ltd vs Peers

Jointown Pharmaceutical Group Co Ltd
Glance View

Company

Help

Tools

Stocks

	Johnson & Johnson NYSE:JNJ	142.92 USD 0.46%
	Bank of America Corp NYSE:BAC	44.775 USD -3.11%
	Mastercard Inc NYSE:MA	504.1101 USD -2.38%
	Salesforce Inc NYSE:CRM	317.8 USD -2.78%
	Abbvie Inc NYSE:ABBV	176.28 USD -1.24%
	Home Depot Inc NYSE:HD	390.14 USD 0.76%

	Arista Networks Inc NYSE:ANET	113.825 USD -1.46%
	Visa Inc NYSE:V	306.83 USD -1.85%
	Texas Pacific Land Corp NYSE:TPL	1 303.78 USD 2.18%
	KLA Corp NASDAQ:KLAC	677.89 USD -1.21%
	Manhattan Associates Inc NASDAQ:MANH	264.355 USD -2.99%
	Pinduoduo Inc NASDAQ:PDD	95.17 USD -5.13%

	Salesforce Inc NYSE:CRM	317.8 USD -2.78%
	ServiceNow Inc NYSE:NOW	1 021.52 USD -2.63%
	EOG Resources Inc NYSE:EOG	130.5125 USD 1.6%
	Copart Inc NASDAQ:CPRT	55.58 USD -2.11%
	Applied Materials Inc NASDAQ:AMAT	169.97 USD -3.97%
	Synopsys Inc NASDAQ:SNPS	485.52 USD -3.28%

	Johnson & Johnson NYSE:JNJ	142.92 USD 0.46%
	Berkshire Hathaway Inc NYSE:BRK.A	661 765.325 USD -2.38%
	Bank of America Corp NYSE:BAC	44.775 USD -3.11%
	Mastercard Inc NYSE:MA	504.1101 USD -2.38%
	UnitedHealth Group Inc NYSE:UNH	527.08 USD 0.49%
	Exxon Mobil Corp NYSE:XOM	106.24 USD -0.65%

600998 vs Shanghai Composite

Stocks Performance 600998 vs Shanghai Composite

Performance Gap 600998 vs Shanghai Composite

Performance By Year 600998 vs Shanghai Composite

Competitors Performance Jointown Pharmaceutical Group Co Ltd vs Peers

Jointown Pharmaceutical Group Co Ltd Glance View

Company

Help

Tools

Stocks

600998

vs

Shanghai Composite

Stocks Performance
600998 vs Shanghai Composite

Performance Gap
600998 vs Shanghai Composite

Performance By Year
600998 vs Shanghai Composite

Competitors Performance
Jointown Pharmaceutical Group Co Ltd vs Peers

Jointown Pharmaceutical Group Co Ltd
Glance View